Potential option for treating chronic kidney disease

New clinical research indicates the drug tetrahydrobiopterin may be able to dial back over-activation of the sympathetic nervous system in chronic kidney disease. New clinical research indicates the drug tetrahydrobiopterin may be able to dial back this overactivation, leading to positive effects on the sympathetic nervous system and some measures of arterial stiffness. —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *